Varieties: | Other |
---|---|
Component: | Chemical Synthetic Drugs |
Type: | Other |
Pharmacodynamic Influential Factors: | Other |
Storage Method: | Prevent Exceeding Quality Guarantee Period |
Veterinary Reg. No.: | Other |
Customization: |
---|
Suppliers with verified business licenses
Product Name | Norfloxacin |
Synonyms | 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylica;
ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylica;
am-715;MK-366;NORFLOXACINE;NORFLOXACIN LACTATE;NORFLOXACIN;noroxin |
CAS | 70458-96-7 |
MF | C16H18FN3O3 |
MW | 319.33 |
EINECS | 274-614-4 |
Product Categories | Pharmaceutical;Active Pharmaceutical Ingredients;APIs;Intermediates & Fine Chemicals;Pharmaceuticals;API's;Aromatics;Heterocycles;Pharmaceutical intermediates;NOROXIN |
TEST | SPECIFICATION | RESULT | |
Description | White to pale yellow,hydroscpion, photosensitive, crystalline powder |
Complies | |
Related Substances | Impurity E | max.0.1% | 0.01% |
Methyl-Norfloxacin | max.0.15% | 0.08% | |
Unspecicifed Impurities | max.0.1% | 0.04% | |
Total Impurities | max.0.5% | 0.2% | |
Loss on drying | max.1.0% | 0.3% | |
Residue on ignition | max.0.1% | 0.05% | |
Heavy metals | max.15ppm | 10ppm | |
Assay | 99.0%-101.0% | 99.8% |
Suppliers with verified business licenses